Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice

被引:32
作者
Chiba, Tsuyoshi [1 ]
Suzuki, Sachina [1 ]
Sato, Yoko [1 ]
Itoh, Tatsuki [2 ]
Umegaki, Keizo [1 ]
机构
[1] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo, Japan
[2] Kinki Univ, Fac Agr, Dept Food Sci & Nutr, Naka, Nara, Japan
来源
PLOS ONE | 2016年 / 11卷 / 10期
关键词
LIVER-DISEASE; METABOLIC SYNDROME; MODEL; FIBROSIS; MOUSE; INFLAMMATION; PROGRESSION; RESISTANCE; IMPACT; RATS;
D O I
10.1371/journal.pone.0164191
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A methionine-and choline-deficient diet is used to induce NASH in mice; however, this diet also causes severe body weight loss. To resolve this issue, we examined the effects of methionine content in a high-fat and choline-deficient (HFCD) diet on body weight and the development of NASH in mice. Methods C57BL/6J mice (male, 10 weeks of age) were fed an L-amino acid rodent (control) diet, high-fat (HF) diet, or HFCD diet containing various amounts of methionine (0.1-0.6% (w/w)) for 12 weeks. Plasma lipid levels, hepatic lipid content and inflammatory marker gene expression were measured, and a pathological analysis was conducted to evaluate NASH. Results The 0.1% methionine in HFCD diet suppressed body weight gain, which was lower than that with control diet. On the other hand, the 0.2% methionine in HFCD diet yielded similar body weight gains as the control diet, while more than 0.4% methionine showed the same body weight gains as the HF diet. Liver weights and hepatic lipid contents were the greatest with 0.1% methionine and decreased in a methionine dose-dependent manner. Pathological analysis, NAFLD activity scores and gene expression levels in the liver revealed that 0.1% and 0.2% methionine for 12 weeks induced NASH, whereas 0.4% and 0.6% methionine attenuated the induction of NASH by HFCD diet. However, the 0.2% methionine in HFCD diet did not induce insulin resistance, despite the body weight gain. Conclusions The 0.2% methionine in HFCD diet for 12 weeks was able to induce NASH without weight loss.
引用
收藏
页数:17
相关论文
共 36 条
  • [1] Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
    Anstee, Quentin M.
    Targher, Giovanni
    Day, Christopher P.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) : 330 - 344
  • [2] Avila M. A., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P267, DOI 10.2174/1568016054368197
  • [3] Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis IMPACT ON MITOCHONDRIAL S-ADENOSYL-L-METHIONINE AND GLUTATHIONE
    Caballero, Francisco
    Fernandez, Anna
    Matias, Nuria
    Martinez, Laura
    Fucho, Raquel
    Elena, Montserrat
    Caballeria, Joan
    Morales, Albert
    Fernandez-Checa, Jose C.
    Garcia-Ruiz, Carmen
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (24) : 18528 - 18536
  • [4] Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
    Charlton, Michael
    Krishnan, Anuradha
    Viker, Kimberly
    Sanderson, Schuyler
    Cazanave, Sophie
    McConico, Andrea
    Masuoko, Howard
    Gores, Gregory
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2011, 301 (05): : G825 - G834
  • [5] Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground
    Chitturi, Shivakumar
    Wong, Vincent Wai-Sun
    Farrell, Geoff
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 163 - 172
  • [6] Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
    Clapper, Jason R.
    Hendricks, Michelle D.
    Gu, Guibao
    Wittmer, Carrie
    Dolman, Carrie S.
    Herich, John
    Athanacio, Jennifer
    Villescaz, Christiane
    Ghosh, Soumitra S.
    Heilig, Joseph S.
    Lowe, Carolyn
    Roth, Jonathan D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 305 (07): : G483 - G495
  • [7] Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1
    Delerive, P
    De Bosscher, K
    Besnard, S
    Vanden Berghe, W
    Peters, JM
    Gonzalez, FJ
    Fruchart, JC
    Tedgui, A
    Haegeman, G
    Staels, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32048 - 32054
  • [8] Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
    Eguchi, Yuichiro
    Hyogo, Hideyuki
    Ono, Masafumi
    Mizuta, Toshihiko
    Ono, Naofumi
    Fujimoto, Kazuma
    Chayama, Kazuaki
    Saibara, Toshiji
    [J]. JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 586 - 595
  • [9] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [10] PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
    Francque, Sven
    Verrijken, An
    Caron, Sandrine
    Prawitt, Janne
    Paumelle, Rejane
    Derudas, Bruno
    Lefebvre, Philippe
    Taskinen, Marja-Riitta
    Van Hul, Wim
    Mertens, Ilse
    Hubens, Guy
    Van Marck, Eric
    Michielsen, Peter
    Van Gaal, Luc
    Staels, Bart
    [J]. JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 164 - 173